Precision Medicine & Targeted Therapies

Precision medicine relies on accurate pathological assessment to guide targeted treatments tailored to individual patient profiles. This track emphasizes the implementation of biomarkers for patient stratification, monitoring therapeutic responses, and predicting outcomes. Coverage includes antibody-drug conjugates, immune checkpoint inhibitors, and personalized cancer vaccines. Sessions explore integrating multidisciplinary data—morphological, molecular, and clinical—to optimize therapy choice. Advances in neoadjuvant and adjuvant therapies, resistance mechanisms, and molecular tumor boards inform discussions. The track highlights challenges such as accessibility, cost-effectiveness, and equitable delivery of precision therapies worldwide. It aims to inspire innovative approaches that translate laboratory discoveries into transformative clinical interventions, ultimately enhancing patient survival and quality of life.

    Related Conference of Precision Medicine & Targeted Therapies

    March 26-27, 2026

    24th Annual Pathology Congress

    Dubai, UAE
    June 22-23, 2026

    24th European Pathology Congress

    Paris, France
    July 23-24, 2026

    6th World Pathology Conference

    Amsterdam, Netherlands

    Precision Medicine & Targeted Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in